Blood Compatible Polymers Market to Record an Exponential CAGR by 2025
Demand
for substitutes for biomedical therapies is rising at a rapid space.
These substitutes are called biomaterials, and they do not react with
biological systems. Direct contact between blood and any biological
material could sustain with the help of some heparin-based
anticoagulant or antithrombotic treatment, but the biological system
have some time span. This treatment is used to avoid clotting of
blood. After many years of research, it was observed that polymers
can be used for biomedical purposes as they help sove the problems
mentioned above. Polymers that are blood compatible consist of
antithrombogenic biomaterial that does not include blood-soluble
additives either. Biocompatible polymers are used to interface with
biological systems to treat, evaluate, replace, and augment any
organ, function, or tissue.
Read
Report Overview @
The
blood compatible polymers market is driven by the biomedical and
pharmaceutical end-use industries. Blood compatible polymers have
various advantages over the other biomedical devices. They have been
used extensively used over the last two decades. However, blood
compatible polymers need to be made at a particular composition of
polymers. Several techniques are used to gain desired properties of
polymers to make them blood compatible. These techniques need highly
skilled workers and adequate laboratory facilities. Hence, lack of
skilled workers and laboratory facilities are likely to restrain the
global blood compatible polymers market.
Blood
compatible polymers are used in various biomedical and blood
contacting devices. They are used for tissue culture, tissue
scaffolds, and wildlife vaccination. These polymers are needed for
vascular prostheses, neurostimulators, heart pacemakers, heart
valves, orthopedic joints, cochlear implants, ophthalmic implants,
and many more. Blood compatible polymers are used for dental
applications such as composites for teeth and crowning, repair of
chipped tooth, replacement of teeth, etc. They are also used for drug
delivery. Biodegradable polymers are injected into blood to release
cancer fighting drugs.
The
blood compatible polymers market can be segmented based on the type
of polymer which are used. Polyvinylchloride,
polytetrafluoroethylene, polyethersulfone, polyethylene,
polyetheretherketone, polysulfone, and polypropalene are some of the
blood compatible polymers. Polyvinylchloride is used in blood bags
and blood tubing. Polytetrafluoroethylene has its application in
endoscopes, synthetic blood vessels, surgical sutures, tubing,
cannulas, catheter linings, etc. Polyethersulfone is used for tubing
and catheters. Polyethylene is used for orthopedic sutures and
artificial tendons. Polyetheretherketone is used in dentistry
products and rigid tubing. Polysulfone is used in surgical and
medical devices, clamps, artificial heart components, and heart
valves. Polyprolene is used in heart valve devices.
Based
on region, the blood compatible polymers market can be segmented into
North America, Europe, Asia Pacific, Latin America, and Middle East &
Africa. Asia Pacific is a prominent region of the blood compatible
polymers market and is expected to continue leading the market during
the forecast period. North America and Europe are expected to
dominate the global blood compatible polymers market throughout the
forecast period. Demand for blood compatible polymers is primarily
driven by rising penetration of blood compatible polymers in various
applications, such as wound management and cosmetic surgery, and
advancements in biotechnology. Further, rising medical expenditure in
the region and increasing awareness regarding health and fitness are
expected to boost the blood compatible polymers market. Increasing
investment in the medical sectors in countries such as India, China,
and Indonesia in Asia Pacific and rise in disposable income of the
middle class are expected to drive the blood compatible polymers
market over the forecast period. The market in Middle East &
Africa is expected to expand at a steady pace over the forecast
period.
Request
to view Sample Report:
Some
of the key companies in the global blood compatible polymers market
are AdvanSource Biomaterials Corporation, Sanofi S.A. , Baxter
International Inc., ASM International, Biomaterial USA LLC., Eastman
Chemical Company, Evonik Industries AG, The Dow Chemical Company,
Jiangsu Senolo Medical Technology Co., Ltd., and TOPAS Advanced
Polymers GmbH.
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and techniques to
gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
Transparency
Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel:
+1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Comments
Post a Comment